Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

AeroVironment (AVAV) Beats On Q2 Earnings, Lifts '19 EPS View

Published 11/29/2018, 08:05 PM
Updated 07/09/2023, 06:31 AM
BA
-
TXT
-
AVAV
-
TDY
-

AeroVironment, Inc. (NASDAQ:AVAV) reported second-quarter fiscal 2019 earnings per share (EPS) from continuing operations of 29 cents, beating the Zacks Consensus Estimate of 16 cents by 81.3%. Earnings however declined 9.4% from the year-ago quarter’s 32 cents.

Operational Performance

Revenues of $73 million increased 11% on a year-over-year basis, driven by a 49% improvement in service revenues to $26 million, which outweighed the 2.8% decline in product revenues to $47.1 million.

As of Oct 27, 2018, the company’s funded backlog was $163.9 million, up 44.4% year over year.

Gross margin contracted 700 basis points to 39% from the year-ago quarter’s 46%.

Total operating expenses increased 10.9% to $21.8 million, thanks to a 6.9% rise in selling, general and administrative expenses and 18.4% hike in research and development costs. Consequently, operating income of $6.6 million showed a decline of 37% from $10.5 million a year ago.

AeroVironment, Inc. Price, Consensus and EPS Surprise

AeroVironment, Inc. Price, Consensus and EPS Surprise | AeroVironment, Inc. Quote

Financial Update

AeroVironment ended the reported quarter with cash and cash equivalents of $151.3 million, up from $143.5 million as of Apr 30, 2018.

Operating cash flow totaled $2.7 million at end of Oct 27, 2018, significantly down from $30 million at the end of Oct 28, 2017.

2019 Guidance

For fiscal 2019, AeroVironment has updated its financial guidance. The company now expects to generate revenue from continuing operations in the range of $300-$310 million, compared to prior $290-$310 million.

The company raised its earnings per share guidance from the prior range of $1.10-$1.40 to $1.30-$1.50, at 5% ownership of the HAPSMobile, Inc. joint venture.

Zacks Rank

AeroVironment currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Other Defense Releases

Textron (NYSE:TXT) reported third-quarter 2018 adjusted earnings from continuing operations of 61 cents per share, which missed the Zacks Consensus Estimate of 76 cents by 19.7%. The bottom line declined 6.2% from 65 cents in the year-ago quarter.

Boeing (NYSE:BA) reported adjusted earnings of $3.58 per share for third-quarter 2018, beating the Zacks Consensus Estimate of $3.45 by 3.8%. The bottom line reflected an improvement of 36.6% from $2.62 a year ago.

Teledyne Technologies (NYSE:TDY) reported adjusted third-quarter 2018 earnings of $2.23 per share, beating the Zacks Consensus Estimate of $2.05 by 8.8%. The bottom line improved 26% from the year-ago quarter’s $1.77.

3 Medical Stocks to Buy Now

The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.

So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.

See them today for free >>



The Boeing Company (BA): Free Stock Analysis Report

Teledyne Technologies Incorporated (TDY): Get Free Report

AeroVironment, Inc. (AVAV): Free Stock Analysis Report

Textron Inc. (TXT): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.